AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Daily Turnover | The turnover of Kindly MD on 5/22 was $287.94 Million, Ranking 323
ByAinvest
Thursday, May 22, 2025 6:00 pm ET1min read
The turnover of Kindly MD on 5/22/2025 was $287.94 million, ranking 323 in today's market, the Volume is 10.25 million.
Kindly MD(KDLY) shares closed at $24.94, up 9.24% on 5/22/2025, up 79.94% in the last 5 trading days, up 1226.60% this month, up 1911.29% year-to-date and up 355.11% in the last 52 weeks.
*If the company has been listed for less than 52 weeks, the 52-week gain is the gain since the listing.
(The same applies for less than 1 month, or less than 5 trading days)
【History Turnover】
| Date | Turnover | Volume | Price | Performance |
|---|---|---|---|---|
| 5/22/2025 | $287.94 million | 10.25 million | $24.94 | 9.24% |
| 5/21/2025 | $229.25 million | 11.23 million | $22.83 | 50.00% |
| 5/20/2025 | $29.80 million | 2.01 million | $15.22 | 9.03% |
| 5/19/2025 | $41.67 million | 2.89 million | $13.96 | 7.80% |
| 5/16/2025 | $59.86 million | 4.56 million | $12.95 | -6.57% |
【Company Profile】
Kindly MD, Inc. was formed on December 2, 2019 in the Utah. The company is located in Salt Lake City, Utah and is a healthcare and healthcare data company, focused on holistic pain management and aiding in the fight against the opioid epidemic. The company offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, The company is working to develop patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with evidence based behavioral therapy and non-opioid alternatives.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet